Cargando…

Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities

BACKGROUND: Retromolar trigone squamous cell carcinoma is relatively uncommon and due to its complex anatomy has always remained a challenge in terms of loco-regional control and survival. Surgery, radiotherapy, and chemotherapy as combined modalities have been used but high recurrence rates result...

Descripción completa

Detalles Bibliográficos
Autores principales: Faisal, Muhammad, Abbas, Taskheer, Khaleeq, Usman, Adeel, Mohammad, Anwer, Abdul Wahid, Hussain, Raza, Jamshed, Arif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451270/
https://www.ncbi.nlm.nih.gov/pubmed/28580200
http://dx.doi.org/10.7759/cureus.1203
_version_ 1783240141468336128
author Faisal, Muhammad
Abbas, Taskheer
Khaleeq, Usman
Adeel, Mohammad
Anwer, Abdul Wahid
Hussain, Raza
Jamshed, Arif
author_facet Faisal, Muhammad
Abbas, Taskheer
Khaleeq, Usman
Adeel, Mohammad
Anwer, Abdul Wahid
Hussain, Raza
Jamshed, Arif
author_sort Faisal, Muhammad
collection PubMed
description BACKGROUND: Retromolar trigone squamous cell carcinoma is relatively uncommon and due to its complex anatomy has always remained a challenge in terms of loco-regional control and survival. Surgery, radiotherapy, and chemotherapy as combined modalities have been used but high recurrence rates result in poor outcome. METHODS: We have retrospectively evaluated records of 62 patients treated in Head and Neck Oncology unit of Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH and RC), Lahore, Pakistan from 2004 to 2014 who were included based on the criteria of histopathological proven squamous cell carcinoma of retromolar trigone (RMT) treated with radical intent. Diagnostic workup for all patients involved clinical examination, imaging modalities usually magnetic resonance imaging (MRI), computerized tomography (CT), Orthopantomogram (OPG), and chest x-ray (CXR) to evaluate regional and distant metastasis, respectively. Kaplan-Meier survival curves were used to depict survival. RESULTS: The study was comprised of 36 male and 26 female patients. Treatment modalities used are surgery only (n = 1), radiotherapy alone (n = 13), radiotherapy followed by surgery (n = 10), chemoradiotherapy (n = 16), induction chemotherapy followed by concurrent chemoradiotherapy (n = 19), induction chemotherapy followed by surgery, and radiotherapy (n = 2). Surgical interventions include wide local excisions (n = 6), marginal mandibulectomy (n = 4), and segmental mandibulectomy (n = 4). Surgical margins were clear in 54%, close in 38%, and involved in 8% of patients. AJCC 7th edition showed cT1 8%, cT2 22%, cT3 14%, and cT4 56% while pT1 2%, pT2 3%, and pT4 8%. During follow-up, 18% patients have come up with local recurrence, 22% showed persistent disease while 9% have presented with distant metastasis. The five-year and overall survivals are 38% and 22%, respectively. CONCLUSION: Retromolar trigone involvement poses many vital structures at risk of involvement. Late presentation results in involvement of masticator space compromising both mouth opening and surgical outcomes. Surgery and radiotherapy have shown comparable results in disease control. Bone invasion has shown poor outcome in terms of loco-regional control and overall survival.
format Online
Article
Text
id pubmed-5451270
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-54512702017-06-02 Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities Faisal, Muhammad Abbas, Taskheer Khaleeq, Usman Adeel, Mohammad Anwer, Abdul Wahid Hussain, Raza Jamshed, Arif Cureus Oncology BACKGROUND: Retromolar trigone squamous cell carcinoma is relatively uncommon and due to its complex anatomy has always remained a challenge in terms of loco-regional control and survival. Surgery, radiotherapy, and chemotherapy as combined modalities have been used but high recurrence rates result in poor outcome. METHODS: We have retrospectively evaluated records of 62 patients treated in Head and Neck Oncology unit of Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH and RC), Lahore, Pakistan from 2004 to 2014 who were included based on the criteria of histopathological proven squamous cell carcinoma of retromolar trigone (RMT) treated with radical intent. Diagnostic workup for all patients involved clinical examination, imaging modalities usually magnetic resonance imaging (MRI), computerized tomography (CT), Orthopantomogram (OPG), and chest x-ray (CXR) to evaluate regional and distant metastasis, respectively. Kaplan-Meier survival curves were used to depict survival. RESULTS: The study was comprised of 36 male and 26 female patients. Treatment modalities used are surgery only (n = 1), radiotherapy alone (n = 13), radiotherapy followed by surgery (n = 10), chemoradiotherapy (n = 16), induction chemotherapy followed by concurrent chemoradiotherapy (n = 19), induction chemotherapy followed by surgery, and radiotherapy (n = 2). Surgical interventions include wide local excisions (n = 6), marginal mandibulectomy (n = 4), and segmental mandibulectomy (n = 4). Surgical margins were clear in 54%, close in 38%, and involved in 8% of patients. AJCC 7th edition showed cT1 8%, cT2 22%, cT3 14%, and cT4 56% while pT1 2%, pT2 3%, and pT4 8%. During follow-up, 18% patients have come up with local recurrence, 22% showed persistent disease while 9% have presented with distant metastasis. The five-year and overall survivals are 38% and 22%, respectively. CONCLUSION: Retromolar trigone involvement poses many vital structures at risk of involvement. Late presentation results in involvement of masticator space compromising both mouth opening and surgical outcomes. Surgery and radiotherapy have shown comparable results in disease control. Bone invasion has shown poor outcome in terms of loco-regional control and overall survival. Cureus 2017-05-01 /pmc/articles/PMC5451270/ /pubmed/28580200 http://dx.doi.org/10.7759/cureus.1203 Text en Copyright © 2017, Faisal et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Faisal, Muhammad
Abbas, Taskheer
Khaleeq, Usman
Adeel, Mohammad
Anwer, Abdul Wahid
Hussain, Raza
Jamshed, Arif
Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities
title Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities
title_full Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities
title_fullStr Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities
title_full_unstemmed Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities
title_short Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities
title_sort treatment outcomes of rare retromolar trigone squamous cell carcinoma using combined modalities
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451270/
https://www.ncbi.nlm.nih.gov/pubmed/28580200
http://dx.doi.org/10.7759/cureus.1203
work_keys_str_mv AT faisalmuhammad treatmentoutcomesofrareretromolartrigonesquamouscellcarcinomausingcombinedmodalities
AT abbastaskheer treatmentoutcomesofrareretromolartrigonesquamouscellcarcinomausingcombinedmodalities
AT khaleequsman treatmentoutcomesofrareretromolartrigonesquamouscellcarcinomausingcombinedmodalities
AT adeelmohammad treatmentoutcomesofrareretromolartrigonesquamouscellcarcinomausingcombinedmodalities
AT anwerabdulwahid treatmentoutcomesofrareretromolartrigonesquamouscellcarcinomausingcombinedmodalities
AT hussainraza treatmentoutcomesofrareretromolartrigonesquamouscellcarcinomausingcombinedmodalities
AT jamshedarif treatmentoutcomesofrareretromolartrigonesquamouscellcarcinomausingcombinedmodalities